Fundraising Fox

Capable

6 known investors

Find your way into Capable

Capable is a vertically integrated, AI-enabled deeptech platform developing peptide and nucleotide therapeutics using automated polymer synthesis, drawing on rare human genetic variants. Its first programs focus on sleep, targeting rare sleep diseases such as narcolepsy and hypersomnia with therapeutics aimed at improving cognitive performance under sleep deprivation.

AI & Machine LearningBiotechDeep Tech

Investors · 6

GoAhead VenturesMenlo Park · $500K – $1M
Harpoon VenturesSan Diego · $100K – $5M
HOF CapitalNew York · $25K – $15M
Able Partnersreported · 2 sourcesNew York · $500K – $3M
AlleyCorpreported · 2 sourcesNew York · $1M – $5M
M13reported · 2 sourcesNew York · $4M – $7M

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Thoughtful AI Launches Human-Capable AI Agents, Raises $20M in New Funding | Healthcare IT Todayhealthcareittoday.com · Jul 2024Zeta Labs Raises $2.9M Pre-Seed Funding, Launches JACE - First AI Agent Capable of Complex Task Completionprnewswire.com · Jun 2024Capable Health Raises $6M for its Health Tech Infrastructure Platform That’s Fueling Innovation in Digital Healthalleywatch.com · May 2022Capable Health Raises $6M to Underpin The Next Revolution in U.S. Healthcareprnewswire.com · May 2022Capable Health Raises $6M in Seed Fundingfinsmes.com · May 2022

Frequently asked questions

What does Capable do?
Capable is a vertically integrated, AI-enabled deeptech platform developing peptide and nucleotide therapeutics using automated polymer synthesis, drawing on rare human genetic variants. Its first programs focus on sleep, targeting rare sleep diseases such as narcolepsy and hypersomnia with therapeutics aimed at improving cognitive performance under sleep deprivation.
Who are Capable's investors?
Capable's investors include GoAhead Ventures, Harpoon Ventures, HOF Capital, Able Partners, AlleyCorp, M13.